Gilpin Wealth Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$179 Sell
5
-1
-17% -$35 ﹤0.01% 1156
2026
Q2
$189 Buy
6
+3
+100% +$127 ﹤0.01% 935
2026
Q1
$166 Buy
+3
New +$143 ﹤0.01% 893

Other funds holding PAHC

Gilpin Wealth Management's PAHC Position: Q3 2026 in Review

Gilpin Wealth Management reduced its Phibro Animal Health (PAHC) stake by 17% in Q3 2026, selling an estimated $35 and leaving 5 shares worth $179. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

Gilpin Wealth Management first reported a position in PAHC in Q1 2026 and has held it in 3 quarters since. The position peaked at $189 in Q2 2026. 10 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Gilpin Wealth Management held 5 shares of Phibro Animal Health worth $179 as of Q3 2026.
  • Gilpin Wealth Management sold 1 Phibro Animal Health share in Q3 2026, an estimated $35.
  • Phibro Animal Health made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1156 holding.
  • Gilpin Wealth Management first reported a position in Phibro Animal Health in Q1 2026 and has held it in 3 quarters since.
  • Gilpin Wealth Management's Phibro Animal Health position peaked at $189 in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.